These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34753063)

  • 1. Ultra-sensitive techniques for detecting neurological biomarkers: Prospects for early diagnosis.
    Kumar D; Hassan MI
    Biochem Biophys Res Commun; 2021 Dec; 584():15-18. PubMed ID: 34753063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson disease: PD biomarkers-use of α-synuclein reaches new levels.
    Montine TJ
    Nat Rev Neurol; 2011 May; 7(6):308-9. PubMed ID: 21556033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs as biomarkers of neurodegenerative disorders.
    Viswambharan V; Thanseem I; Vasu MM; Poovathinal SA; Anitha A
    Biomark Med; 2017 Feb; 11(2):151-167. PubMed ID: 28125293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
    Puranik N; Yadav D; Yadav SK; Chavda VK; Jin JO
    Curr Protein Pept Sci; 2020; 21(12):1174-1183. PubMed ID: 32392110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence-coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases.
    Kavungal D; Magalhães P; Kumar ST; Kolla R; Lashuel HA; Altug H
    Sci Adv; 2023 Jul; 9(28):eadg9644. PubMed ID: 37436975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking backward to move forward: early detection of neurodegenerative disorders.
    DeKosky ST; Marek K
    Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker discovery in neurodegenerative diseases: a proteomic approach.
    Shi M; Caudle WM; Zhang J
    Neurobiol Dis; 2009 Aug; 35(2):157-64. PubMed ID: 18938247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways to primary neurodegenerative disease.
    Hardy J
    Mayo Clin Proc; 1999 Aug; 74(8):835-7. PubMed ID: 10473363
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
    Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
    Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of proteomics in biomarker discovery in neurodegenerative diseases.
    Davidsson P; Sjögren M
    Dis Markers; 2005; 21(2):81-92. PubMed ID: 15920295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
    Shaw LM; Korecka M; Clark CM; Lee VM; Trojanowski JQ
    Nat Rev Drug Discov; 2007 Apr; 6(4):295-303. PubMed ID: 17347655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.
    Schaffer C; Sarad N; DeCrumpe A; Goswami D; Herrmann S; Morales J; Patel P; Osborne J
    J Lab Autom; 2015 Oct; 20(5):589-600. PubMed ID: 25424384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enlightening the advancements in electrochemical bioanalysis for the diagnosis of Alzheimer's disease and other neurodegenerative disorders.
    Serafín V; Gamella M; Pedrero M; Montero-Calle A; Razzino CA; Yáñez-Sedeño P; Barderas R; Campuzano S; Pingarrón JM
    J Pharm Biomed Anal; 2020 Sep; 189():113437. PubMed ID: 32629192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.
    Dupiereux I; Zorzi W; Quadrio I; Perret-Liaudet A; Kovacs GG; Heinen E; Elmoualij B
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):2-11. PubMed ID: 20021333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposable immunoplatforms for the simultaneous determination of biomarkers for neurodegenerative disorders using poly(amidoamine) dendrimer/gold nanoparticle nanocomposite.
    Serafín V; Razzino CA; Gamella M; Pedrero M; Povedano E; Montero-Calle A; Barderas R; Calero M; Lobo AO; Yáñez-Sedeño P; Campuzano S; Pingarrón JM
    Anal Bioanal Chem; 2021 Jan; 413(3):799-811. PubMed ID: 32474723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between Alzheimer disease and cataract].
    Liu SS; Zhu SQ
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):314-316. PubMed ID: 28412806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
    Cedazo-Minguez A; Winblad B
    Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.